1Y Annualised Return
▼-25.83%
3Y Annualised Return
▲16.46%
5Y Annualised Return
▲19.60%
|
|
|
Over the past
Market Cap (in crs)
403.61
Face Value
10
Turnover (in lacs)
4.75
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
81.37 Cr | 82.5 Cr | 89.11 Cr | 84.6 Cr | 78.46 Cr |
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
349.58 Cr | 309.79 Cr | 318.63 Cr | 351.81 Cr | 267.37 Cr | 263.06 Cr |
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
6.43 Cr | 4.38 Cr | 3.48 Cr | 4.85 Cr | 3.3 Cr |
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
18.73 Cr | 6.33 Cr | 11.38 Cr | 25.3 Cr | 13.56 Cr | 10.18 Cr |
SMS Lifesciences India Ltd reported a 2.0% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Sep (Q2 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 1.6%.
Its expenses for the quarter were down by 4.1% QoQ and 3.3% YoY.
The net profit increased 46.2% QoQ and increased 94.5% YoY.
The earnings per share (EPS) of SMS Lifesciences India Ltd stood at 20.19 during Q2 FY 2025-26.
Data Source: BSE, Company announcements
The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.
| Period | Combined Delivery Volume | NSE+BSE Traded Volume |
|---|---|---|
Day Rs | 362 Rs | 362 Rs |
Week Rs | 1140 Rs | 1323 Rs |
Month Rs | 2196 Rs | 3357 Rs |
| Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
437.15 | 424.50 | 142.1 | 477 | 411.70 | 3.05% | 13.08% | 4.83% | 206.66% | 246.81% | 0.00% | 64.19 | 41.70 | 5.85 | |
341.90 | 412.34 | 305 | 625 | 347.05 | -6.64% | -14.78% | -25.27% | 1.05% | 311.68% | 0.00% | 0.00 | 41.70 | 17.15 | |
53.83 | 446.70 | 37.18 | 79.83 | 53.32 | 3.30% | 8.88% | 3.18% | 7.96% | -14.05% | 0.00% | 39.11 | 41.70 | 6.65 | |
303.20 | 352.99 | 222 | 324.95 | 305.00 | -3.97% | 1.07% | 11.80% | 8.29% | 142.56% | 0.00% | 22.34 | 41.70 | 4.21 | |
71.63 | 389.04 | 63.86 | 120.92 | 64.57 | 7.97% | -14.22% | -27.94% | -33.61% | 0.00% | 0.00% | 57.20 | 41.70 | 1.23 | |
103.24 | 400.87 | 99.05 | 154.4 | 101.82 | -2.82% | -15.74% | 0.00% | 0.00% | 0.00% | 0.00% | 28.53 | 41.70 | 1.89 |
Haleos Labs share price is ₹1335 in NSE and ₹1368.25 in BSE as on 5/12/2025.
Haleos Labs share price in the past 1-year return was 14.39. The Haleos Labs share hit a 1-year low of Rs. 959.8 and a 1-year high of Rs. 1680.
The market cap of Haleos Labs is Rs. 403.61 Cr. as of 5/12/2025.
The PE ratios of Haleos Labs is 21.73 as of 5/12/2025.
The PB ratios of Haleos Labs is 1.99 as of 5/12/2025
You can easily buy Haleos Labs shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
The 52-week high and low of Haleos Labs share price is ₹1680 and ₹959.8 as of 5/12/2025.
The earnings per share (EPS) of SMS Lifesciences India stood at 20.19 during Q2 FY 2025-26.
Please be aware that Haleos Labs stock prices are subject to continuous fluctuations due to various factors.